News & Perspective

Jan 30, 2013

Jan 30, 2013

Study finds post-H1N1-vaccination rise in narcolepsy in 3 nations

(CIDRAP News) – A large study of narcolepsy background rates in six European countries before and after 2009 H1N1 pandemic vaccine campaigns confirmed increases in Finland and Sweden—the two countries that first reported the problem—but also detected a rise in Denmark.

Feb 07, 2013

Feb 07, 2013

Researchers find first US evidence of vaccine-resistant pertussis

(CIDRAP News) – Researchers in other countries have found evidence that circulating strains of Bordetella pertussis have adapted to the acellular vaccine, and researchers today reported similar findings for the first time in US kids, based on genetic analysis of isolates from hospitalized children.

Feb 22, 2013

Feb 22, 2013

Flu activity continues its slow retreat

(CIDRAP News) – Some of the key markers that US officials use to track flu continued to tumble last week, though activity was still elevated in most parts of the country, according to the Centers for Disease Control and Prevention (CDC) today.

Nationally, the percentage of doctors visits for flulike illness fell from 3.2% to 2.8% last week, with all parts of the country still above regional baselines.

Mar 08, 2013

Mar 08, 2013

US flu activity almost back to baseline

(CIDRAP News) – Influenza activity in the United States continued to tumble last week, with one key marker—clinic visits for flulike illness—nearly approaching the national baseline, the US Centers for Disease Control and Prevention (CDC) said today.

Mar 15, 2013

Mar 15, 2013

US flu markers show further signs of decline

(CIDRAP News) – Flu activity in the United States last week continued its slow retreat, with more areas of the country returning to regional baselines and fewer respiratory samples testing positive for the virus.

Aug 09, 2013

Aug 09, 2013

Flu Scan for Aug 09, 2013

H3N2v case in Indiana
H1N1 infection and narcolepsy

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»